References - Therapeutic Strategies in Cancer Biology and Pathology - page 203

Cheng, W.L., Tsai, M.M., Tsai, C.Y., Huang, Y.H., Chen, C.Y., Chi, H.C., et al., 2012c.
Glyoxalase-I is a novel prognosis factor associated with gastric cancer progression. PLoS
ONE 7, e34352.
Chiang, P.C., Thompson, D.C., Ghosh, S., Heitmeier, M.R., 2011. A formulation-enabled pre-
clinical efficacy assessment of a farnesoid X receptor agonist, GW4064, in hamsters and
Cynomolgus monkeys. J. Pharmaceut. Sci. 100, 4722-4733.
Chiba, T., Miyagi, S., Saraya, A., Aoki, R., Seki, A., Morita, Y., et al., 2008. The polycomb
gene product BMI1 contributes to the maintenance of tumor-initiating side population
cells in hepatocellular carcinoma. Cancer Res. 68, 7742-7749.
Ching, Y.P., Wong, C.M., Chan, S.F., Leung, T.H.Y., Ng, D.C.H., Jin, D.Y., et al., 2003.
Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppres-
sor function and is underexpressed in hepatocellular carcinoma. J. Biol. Chem. 278,
10824-10830.
Chinnadurai, G., 2009. The transcriptional corepressor CtBP: a foe of multiple tumor suppres-
sors. Cancer Res. 69, 731-734.
Chishti, A.H., Kim, A.C., Marfatia, S.M., Lutchman, M., Hanspal, M., Jindal, H., et al., 1998.
The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to
the membrane. Trends Biochem. Sci. 23, 281-282.
Cho, J.H., Kim, H.S., Park, C.S., Kim, J.K., Jung, K.Y., Shin, B.K., et al., 2007. Maspin
expression in early oral tongue cancer and its relation to expression of mutant-type p53
and vascular endothelial growth factor (VEGF). Oral. Oncol. 43, 272-277.
Cho, S.H., Park, Y.S., Kim, H.J., Kim, C.H., Lim, S.W., Huh, J.W., et al., 2012. CD44
enhances the epithelial-mesenchymal transition in association with colon cancer inva-
sion. Int. J. Oncol. 41, 211-218.
Choi, U.J., Jee, B.K., Lim, Y., Lee, K.H., 2009. KAI1/CD82 decreases Rac1 expression and
cell proliferation through PI3K/Akt/mTOR pathway in H1299 lung carcinoma cells. Cell.
Biochem. Funct. 27, 40-47.
Chopra, A.P., Boone, S.A., Liang, X., Duesbery, N.S., 2003. Anthrax lethal factor proteolysis
and inactivation of MAPK kinase. J. Biol. Chem. 278, 9402-9406.
Chow, A., Hao, Y., Yang, X., 2010. Molecular characterization of human homologs of yeast
MOB1. Int. J. Cancer 126, 2079-2089.
Christgen, M., Bruchhardt, H., Ballmaier, M., Krech, T., Laenger, F., Kreipe, H., et al., 2008.
KAI1/CD82 is a novel target of estrogen receptor-mediated gene repression and down
regulated in primary human breast cancer. Int. J. Cancer 123, 2239-2246.
Chua, M.S., Sun, H., Cheung, S.T., Mason, V., Higgins, J., Ross, D.T., et al., 2007.
Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma.
Mod. Pathol. 20, 76-83.
Chun, S.G., Zhou, W., Yee, N.S., 2009. Combined targeting of histone deacetylases and
hedgehog signaling enhances cytoxicity in pancreatic cancer. Cancer Biol. Ther. 8,
1328-1339.
Chung, L.C., Tsui, K.H., Feng, T.H., Lee, S.L., Chang, P.L., Juang, H.H., 2012. l-Mimosine
blocks cell proliferation via upregulation of B-cell translocation gene 2 and N-myc
downstream regulated gene 1 in prostate carcinoma cells. Am. J. Physiol. Cell. Physiol.
302, C676-C685.
Chung, T.W., Moon, S.K., Chang, Y.C., Ko, J.H., Lee, Y.C., Cho, G., et al., 2004. Novel and
therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells:
complete regression of hepatoma growth and metastasis by dual mechanism. FASEB J.
18, 1670-1681.